We help you improve your confidence in the genomic stability of your human cell lines so you gain time, credibility and quality in your final product. Strengthen your workflow with a cost-effective solution.
Stem Genomics is a biotech company specialized in the development of innovative testing solutions for research scientists working on human stem cells. We help you assess the genomic stability of your cell lines with specific assays and recommended workflows for the cell type you work with.
Whether you work on Pluripotent Stem Cells (PSCs), Mesenchymal Stromal Cells (MSCs) or other types of human stem cells, we can perform various categories of tests and analyses suited to your specific needs.
Our flagship testing solution, iCS-digital™ PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. We can also perform the following tests for you: G-Banding karyotyping, mycoplasma detection, aneuploidy detection, or design customized assays to meet your requirements.
All our tests will take into account the constraints related to the cell type you work with. With all the assays we perform, you will receive clear, straightforward reports to make it easier to understand the analysis and to support your decision-making process.
Founded in 2018, Stem Genomics is a spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB), co-founded by Professor John de Vos and Dr. Said Assou, experts in stem cell genomic integrity. To date, we have worked with over 150 clients worldwide.
We are quick to respond
Let's talk to each other
According to your availability
Subscribe to stay informed
IRMB – Hôpital Saint Eloi
80 avenue Augustin Fliche
34295 Montpellier Cedex 5 – France
Please enter your e-mail address.
